1. Home
  2. OCGN vs FRST Comparison

OCGN vs FRST Comparison

Compare OCGN & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • FRST
  • Stock Information
  • Founded
  • OCGN 2013
  • FRST 2004
  • Country
  • OCGN United States
  • FRST United States
  • Employees
  • OCGN N/A
  • FRST N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • FRST Major Banks
  • Sector
  • OCGN Health Care
  • FRST Finance
  • Exchange
  • OCGN Nasdaq
  • FRST Nasdaq
  • Market Cap
  • OCGN 283.3M
  • FRST 273.3M
  • IPO Year
  • OCGN N/A
  • FRST 2006
  • Fundamental
  • Price
  • OCGN $1.05
  • FRST $11.09
  • Analyst Decision
  • OCGN Strong Buy
  • FRST Buy
  • Analyst Count
  • OCGN 3
  • FRST 1
  • Target Price
  • OCGN $6.00
  • FRST $420.00
  • AVG Volume (30 Days)
  • OCGN 2.6M
  • FRST 130.1K
  • Earning Date
  • OCGN 08-01-2025
  • FRST 07-24-2025
  • Dividend Yield
  • OCGN N/A
  • FRST 3.64%
  • EPS Growth
  • OCGN N/A
  • FRST N/A
  • EPS
  • OCGN N/A
  • FRST 0.11
  • Revenue
  • OCGN $4,754,000.00
  • FRST $127,561,000.00
  • Revenue This Year
  • OCGN N/A
  • FRST $20.14
  • Revenue Next Year
  • OCGN N/A
  • FRST $28.37
  • P/E Ratio
  • OCGN N/A
  • FRST $99.11
  • Revenue Growth
  • OCGN N/A
  • FRST 19.27
  • 52 Week Low
  • OCGN $0.52
  • FRST $7.59
  • 52 Week High
  • OCGN $1.40
  • FRST $12.95
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 53.85
  • FRST 47.11
  • Support Level
  • OCGN $1.01
  • FRST $10.50
  • Resistance Level
  • OCGN $1.07
  • FRST $11.76
  • Average True Range (ATR)
  • OCGN 0.05
  • FRST 0.32
  • MACD
  • OCGN 0.00
  • FRST -0.05
  • Stochastic Oscillator
  • OCGN 66.48
  • FRST 46.46

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About FRST Primis Financial Corp.

Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit. Its operating segments are Primis Mortgage, Primis Bank, and Other.

Share on Social Networks: